Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Combined Sample Extraction and Whole Genome Sequencing

GENOMICS ENGLAND LIMITED · compiled

Tender information last checkedLast checked 29 Sept 2026, 22:26.

Opportunity overview

Genomics England is contracting for services to deliver accelerated combined extraction and sequencing services in support of the Generation Study programme.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Revvity (UK) Limited

Matched by number
Contract value
£29.2m
Awarded
Not supplied
Contract signed
5 Mar 2025
Award ID
008121-2025-GEL-HE-596-23-1
Status
active
Identifier
GB-COH 03763278
Location
Llantrisant, UK, CF72 8YW, United Kingdom

Classification

  • CPV71900000 — Laboratory services
  • CPV73111000 — Research laboratory services

Lots

  • This Contract Award Notice confirms the award of the contract to the successful supplier to provide sample extraction and whole genome sequencing (WGS) and storage of 44,500 samples within a 7-working-day turnaround time (TAT) service. The procurement was originally advertised under Contract Notice 2023/S 000-036294 but see below for further information regarding the change to the procedure. The Generation Study is the NHS-embedded research study delivered through the Newborn Genomes Programme and aims to explore the benefits, challenges, and practicalities of offering WGS to newborns, to accelerate diagnosis and access to treatment for rare genetic conditions. The Study is divided into two stages and this contract covers the second stage of the study, relating to a combined accelerated extraction and whole genome sequencing only. The study has a a target of an end to end 14-working-day service to participant(s) with Day 1 being the day the sample arrives at the sequencing provider and Day 14 being the delivery of the clinical results to the participant(s). Accelerated Delivery Stage - The Authority has determined that to achieve the 14-working-day service to participant(s), the combined accelerated sample extraction and sequencing service must be conducted in no more than 7-working-days. The service will be scaled to process and store up to 7,000 samples per quarter from July 2025 to March 2027. There is no minimum committed volume within the contract, but it is anticipated that 44,500 samples will be processed within the 21 months of live service. The initial contract will run from the contract signature date in March 2025 to 31st March 2027, with an option to extend by up to 12 months.Value not stated

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
GEL-HE-596-23
Status
complete
Procurement Method
limited
Main Procurement Category
services
Procurement Method Details
Award procedure without prior publication of a call for competition
Why this procedure was chosen
As explained above, Genomics England received no suitable tenders pursuant to the original procurement under the open procedure and therefore exercised its right to negotiate with Revvity (UK) Limited as the only supplier capable of meeting the minimum selection criteria. Genomics England is satisfied that the initial conditions of contract are not substantially altered.

Covered By

GPA

Legal basis

Id
32014L0024
Scheme
CELEX

Classification

Id
71900000
Scheme
CPV
Description
Laboratory services

Procedure reasons

Entry 1
Id
D_PROC_OPEN
Scheme
TED_PT_AWARD_CONTRACT_WITHOUT_CALL
Description
No tenders or no suitable tenders/requests to participate in response to open procedure

Lots and requirements

Entry 1
Id
1
Status
cancelled
Has Options
Yes
Description
This Contract Award Notice confirms the award of the contract to the successful supplier to provide sample extraction and whole genome sequencing (WGS) and storage of 44,500 samples within a 7-working-day turnaround time (TAT) service. The procurement was originally advertised under Contract Notice 2023/S 000-036294 but see below for further information regarding the change to the procedure. The Generation Study is the NHS-embedded research study delivered through the Newborn Genomes Programme and aims to explore the benefits, challenges, and practicalities of offering WGS to newborns, to accelerate diagnosis and access to treatment for rare genetic conditions. The Study is divided into two stages and this contract covers the second stage of the study, relating to a combined accelerated extraction and whole genome sequencing only. The study has a a target of an end to end 14-working-day service to participant(s) with Day 1 being the day the sample arrives at the sequencing provider and Day 14 being the delivery of the clinical results to the participant(s). Accelerated Delivery Stage - The Authority has determined that to achieve the 14-working-day service to participant(s), the combined accelerated sample extraction and sequencing service must be conducted in no more than 7-working-days. The service will be scaled to process and store up to 7,000 samples per quarter from July 2025 to March 2027. There is no minimum committed volume within the contract, but it is anticipated that 44,500 samples will be processed within the 21 months of live service. The initial contract will run from the contract signature date in March 2025 to 31st March 2027, with an option to extend by up to 12 months.

Options

Description
One optional extension of up to 12 months, to be agreed by the parties.

Award criteria

Criteria

Criterion 1
Type
price

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery locations

Entry 1
Region
UK

Additional Classifications

Entry 1
Id
73111000
Scheme
CPV
Description
Research laboratory services

Buyer, suppliers and contacts

Organisation 1
Id
GB-COH-08493132
Name
GENOMICS ENGLAND LIMITED

Roles

buyer

Address

Region
UK
Locality
London
Postal Code
E145AB
Country Name
United Kingdom
Street Address
Level 21 One Canada Square

Details

Classifications

Entry 1
Id
BODY_PUBLIC
Scheme
TED_CA_TYPE
Description
Body governed by public law
Entry 2
Id
07
Scheme
COFOG
Description
Health

Identifier

Id
08493132
Scheme
GB-COH
Legal Name
GENOMICS ENGLAND LIMITED

Contact

Name
Paul Nicholson
Telephone
+44 7702276409
Organisation 2
Id
GB-COH-03763278
Name
Revvity (UK) Limited

Roles

supplier

Address

Region
UK
Locality
Llantrisant
Postal Code
CF72 8YW
Country Name
United Kingdom

Details

Scale
large

Identifier

Id
03763278
Scheme
GB-COH
Legal Name
Revvity (UK) Limited
Organisation 3
Id
GB-FTS-100341
Name
His Majesty's High Court of Justice

Roles

reviewBody

Address

Locality
London
Country Name
United Kingdom

Identifier

Legal Name
His Majesty's High Court of Justice

Award information

Award 1
Id
008121-2025-GEL-HE-596-23-1
Status
active

Suppliers

Supplier 1
Id
GB-COH-03763278
Name
Revvity (UK) Limited

Related lots

1

Contracts and changes

Entry 1
Id
008121-2025-GEL-HE-596-23-1
Status
active
Award ID
008121-2025-GEL-HE-596-23-1
Date Signed
5 Mar 2025, 00:00

Value

Amount
29,200,000
Currency
GBP

Recorded locations

  • Buyer location · London · UK · E145AB · United Kingdom
  • Delivery location · UK

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-04e9ef-2025-03-06T08:47:58Zcompiled ·